Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report
Revolution Medicines, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $163.68
+5.0% in 7d after detection
Post-detection moves
1h
—
1d
-0.9%
3d
+3.2%
7d
+5.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS